Fidaxomicin
API Standard
| Catalog Number | CS-O-30824 |
| Alternative Name(s) | (3E,5E,8S,9E,11S,12R,13E,15E,18S)-3-[[[6-Deoxy-4-O-(3,5yl)-2-O-methyl-β-D-mannopyranosyl]oxy]methyl]-12-[[6-deoxymethyl-1-oxopropyl)-β-D-lyxo-hexopyranosyl]oxy]-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-oxccloctadca-3,5,9,13,15-pentaen-2-one;clostomcin B1; Difcid; Difclir; Fidaxomcin; Fidaxomcin; Lipiarmcin; Lipiarmcin; Lipiarmcin A 3; OPT 80; PAR 01; PAR 101; R-Ticumcin B; Ticumcin B |
| Research Area | Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen. |
| CAS# | 873857-62-6 |
| Purity | >98% |
| SMILES | O=C(C(C(O)=C(Cl)C(O)=C1Cl)=C1CC)O[C@H]([C@H](O[C@H]2OC/C(C(O[C@](C/C=C3C)([H])[C@H](O)C)=O)=CC=CC[C@](/C(C)=C[C@H](CC)[C@@H](O[C@@](OC(C)(C)[C@@H](OC(C(C)C)=O)[C@@H]4O)([H])[C@H]4O)C(C)=C/3)([H])O)C)[C@@H]([C@@H]2OC)O |
| Size | 500 g |
| Supplier Page | https://www.clearsynth.com/en/CSO30824.html |